Clinical trial
A Single-center Study of the Identification and Prognostic Value of Key Genes in Hepatocellular Carcinoma
NCT05759858 is registered in ClinicalTrials.gov with Second Affiliated Hospital, Zhejiang University, School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-center Study of the Identification and Prognostic Value of Key Genes in Hepatocellular Carcinoma
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 14, 2022
- Completion date
- December 31, 2025
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma